Ticker Details
Zai Lab Limited Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.25B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.18 | 2.44%
Avg Daily Range (30 D):	$0.27 | 1.50%
Avg Daily Range (90 D):	$0.28 | 1.36%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.61M
Avg Daily Volume (90 D):	.74M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	79

Institutional Trades
Total Institutional Trades:	3,393
Avg Institutional Trade:	$2.52M
Avg Institutional Trade (30 D):	$1.36M
Avg Institutional Trade (90 D):	$1.72M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.63M
Avg Closing Trade (30 D):	$1.29M
Avg Closing Trade (90 D):	$1.32M
Avg Closing Volume:	50.77K

News

Feb 5, 2026 @ 2:35 PM $207B Market Shift: The Race for Fast Track Approv... Source: Prnewswire

Sep 11, 2025 @ 12:02 PM Zai Lab's Double Whammy: Earnings Miss, Phase 3 Se... Source: Bamboo Works Benzinga Contributor

Jul 16, 2025 @ 10:51 PM Cancer Pipeline Milestones Coming Fast as Regulato... Source: Prnewswire

Jul 7, 2025 @ 5:00 PM Bispecific Antibody Clinical Trial Pipeline Gains ... Source: Delveinsight

Jul 16, 2024 @ 4:32 AM argenx and Zai Lab Announce Approval of Efgartigim... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.03	$-.04
Diluted EPS		$-.03	$-.04
Revenue		$116.1M	$109.98M
Gross Profit		$69.33M	$66.97M
Net Income / Loss		$-35.96M	$-40.73M
Operating Income / Loss		$-48.82M	$-54.9M
Cost of Revenue		$46.76M	$43M
Net Cash Flow		$-15.3M	$-25.1M
PE Ratio